What goes into your decision making when choosing between oral and intravenous bisphosphonate therapies for osteoporosis?
Do you consider the lower risk of MRONJ to motivate you to preferentially choose oral therapy? Does more severe bone disease at baseline move you towards IV?
1 Answer
Mednet MemberInvited Expert
Endocrinology · Boston University School of Medicine
Answered on
From my perspective if you are going to give a bisphosphonate IV is preferred since it is convenient and there is no risks of GI side effects and issues of compliance. I do not think there is any significant difference in causing ONJ and subtrochanteric femoral fractures. However my preference is De...
Join for free or sign in to see the full answer